In reply to Dr. Richardson: I'm not sure we're trying to compete with heroin for price, attractiveness or any other parameter - this is medicine offered to people who WANT to stop using heroin.
First Buccal Therapy Approved for Opioid Dependence — Physician’s First Watch
First Buccal Therapy Approved for Opioid Dependence
By Amy Orciari Herman
The FDA has approved the first mucoadhesive buccal film therapy for the maintenance treatment of opioid dependence, the manufacturer announced on Friday. Bunavail — a combination of buprenorphine and naloxone — should be used along with counseling and psychosocial support.
The manufacturer says that this mode of delivery is more potent and therefore requires half the dose of the currently marketed sublingual formulation (Suboxone). This "may help to reduce the potential for misuse and diversion and potentially lessen the incidence of certain side effects," the company says.